study on [F-18] FDG and [F-18] FLT in the assessment of malignant tumors
Not Applicable
- Conditions
- malignant tumors
- Registration Number
- JPRN-UMIN000029524
- Lead Sponsor
- Department of Diagnostic Radiology,Medical Hospital Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients with blood sugar level over 200mg/dl when they take [F-18] FDG PET/CT 2. patients who are pregnant or have high possibility of pregnancy 3. patients who are unable to give an appropriate consent in terms of mental and legal point of view
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to show improved detectability of primary malignant tumors and their metastases or reccurrences, and the efficacy in the assessment of treatment response and prognosis using [F-18] FLT PET/CT.
- Secondary Outcome Measures
Name Time Method